Key facts
- Angela Caglia Skincare’s last known valuation is $12.5M (Feb 2025).
- It has raised $4.5M; the latest was Seed Round ($3.3M) in Feb 2025.
- Notable investors include Martin Brok.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Angela Caglia Skincare
- ·The full record, as it builds
Funding rounds
No funding rounds for Angela Caglia Skincare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Angela Caglia Skincare
Manufacturer of skincare products designed for anti-aging purposes. The company offers high-potency skincare formulations that harness proprietary stem cell-derived biotechnologies, botanical extracts, and barrier-supporting compositions to reduce fine lines, improve skin texture, and promote a youthful appearance, enabling individuals seeking anti-aging and skin health enhancements to nurture and improve their skin's condition with scientifically informed ingredients.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Gardena, CA, United States
- Founded
- 2016
- Employees
- 9
- Website
- angelacaglia.com/
- Ownership
- Privately Held (backing)
Angela Caglia Skincare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Angela Caglia Skincare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Angela Caglia Skincare in its N-PORT filings yet. We sweep new filings monthly.